Latest filing published 06 Nov 2026 for Teva Pharmaceutical Industries Ltd, €539k.
Filing timeline
BuySaleInsider track record
No signal scores available.
Dov Bergwerk: trading record in brief
All filings by Dov Bergwerk on record concern Teva Pharmaceutical Industries Ltd. In total, 5 filings cover trades dated from 28 February 2024 to 4 November 2026.
No open-market purchase appears, only 2 sales worth €973k. The rest of the record consists of 3 option exercises. 2026 to date brings no purchases and 2 sales.
Most recently, on 6 November 2026, the filings show an option exercise worth €539k in Teva Pharmaceutical Industries Ltd. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Dov Bergwerk
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 17,505 shares@ US$34.70Ordinary SharesSEC:0001193125-26-451804:0
- 17,505 shares@ US$41.72Ordinary SharesSEC:0001193125-26-451804:1
- 8,755 shares@ US$28.98Ordinary SharesSEC:0001193125-26-451804:2
- 8,755 shares@ US$41.72Ordinary SharesSEC:0001193125-26-451804:3
- 6,653 sharesOrdinary SharesSEC:0000950170-24-023532:0
5 of 5 declarations
